How Does Europe Regulate CBD Products? (EU Rules vs. Country-by-Country Laws)

What are Europe’s main rules for CBD?

Europe’s CBD regulation is shaped by two overlapping forces:

• EU-level rules that apply across member states in areas such as food law (including “novel foods”), consumer safety, and labeling.
• National laws and enforcement that determine how CBD products are policed in practice (e.g., whether certain CBD extracts are treated as food, medicine, or controlled substances).

A pivotal EU legal reference point is the European Court of Justice (ECJ) decision in the Kanavape case, which found that CBD is not a narcotic under the 1961 UN Single Convention when it is extracted from the whole plant and does not have psychoactive effects.
That decision influenced how some countries approach bans and cross-border trade.

Key takeaway: EU law can support the free movement of goods, but member states may still restrict products for public health reasons—especially when product category (food vs. medicine) or THC compliance is disputed.

Reference: ECJ, Case C‑663/18 (EUR-Lex).

How does the EU regulate CBD as a “novel food”?

In the EU, many CBD extracts intended to be consumed (for example, CBD oils marketed as supplements) are treated as “novel foods” under Regulation (EU) 2015/2283.
“Novel food” generally means a food that was not consumed to a significant degree in the EU before May 15, 1997 and therefore needs a pre-market safety assessment and authorization.

In practice, this has meant that:

• Businesses may need a novel food authorization before selling ingestible CBD products in EU markets.
• Authorities can take action against ingestible CBD products that are viewed as unauthorized novel foods.
• Timelines and enforcement can vary by country, even when the underlying EU rule is the same.

To avoid overstating specific application counts (which can change and may be reported differently across sources), it’s safest to say: multiple applications have been submitted and reviewed, and regulators have requested additional safety data in several cases.
Readers can verify the up-to-date status via the EU Novel Food Catalogue and EFSA communications.

References:
Regulation (EU) 2015/2283 (EUR-Lex);
EU Novel Food Catalogue (European Commission).

How do CBD rules vary by country (and why)?

Even with EU food law and court decisions, CBD still looks different across Europe because countries may classify and enforce products differently.
Common points of variation include:

• Product category: Is it treated as a food/supplement, cosmetic, medical product, or a controlled substance?
• Source material rules: Some authorities scrutinize whether CBD is derived from hemp fiber/seed vs. flowers/leaves.
• THC compliance approach: Some focus on the THC level in the final product; others also consider trace THC presence, testing uncertainty, or “zero THC” expectations.
• Marketing restrictions: Medical claims can trigger medicinal product rules and enforcement.

Example (high-level): France historically applied stricter interpretations around plant-part sourcing, while other markets have allowed broader retail availability—especially for cosmetics—provided safety and labeling rules are met.
Because national positions change, businesses should confirm requirements with local regulators and qualified counsel before launching.

Internal resource: Brand Story: Ethical Sourcing

THC limits in Europe: what matters for legality?

THC (tetrahydrocannabinol) is the primary intoxicating cannabinoid, and THC limits strongly influence how authorities view CBD products.
However, it’s important to separate two concepts:

• Hemp cultivation rules (what can be grown legally)
• Finished product rules (what can be sold legally)

At EU level, the permitted THC threshold for industrial hemp cultivation has been set at 0.3% THC in the EU’s agricultural policy framework (this is about hemp varieties and farming eligibility, not automatically a “sellable product” limit).
Individual countries may still apply different compliance expectations for finished CBD products, especially ingestibles.

Practical tip: if you’re buying CBD, look for a recent certificate of analysis (COA) from an independent lab showing cannabinoid content, including THC, and matching the batch/lot number on the label.

Reference (EU hemp cultivation context): European Commission agriculture resources on hemp and CAP rules
(European Commission – Agriculture).

Medical vs. wellness CBD: how classification changes the rules

Many European regulators draw a hard line between:

• Medicinal products (used to treat or prevent disease, or presented with therapeutic claims)
• Wellness/consumer products (foods, supplements, cosmetics—where permitted)

If a CBD product is marketed with claims to treat anxiety, pain, epilepsy, inflammation, or other medical conditions, it may be regulated as a medicine—triggering stricter requirements (authorization, quality standards, prescription status, and pharmacovigilance).

A widely cited example of a prescription CBD medicine is Epidyolex (EU brand name), authorized for specific rare epilepsies under specialist care.
This does not mean over-the-counter CBD products are approved to treat those conditions.

Reference: European Medicines Agency (EMA) overview for Epidyolex
(EMA EPAR: Epidyolex).

Internal resource: Guide to Integrative Health Approaches

Who is this guidance for?

• Consumers who want to buy CBD responsibly and avoid mislabeled or non-compliant products.
• Travelers moving between European countries where rules and enforcement may differ.
• Brands and retailers planning cross-border sales and needing a compliance-first overview.

How to choose compliant, higher-quality CBD in Europe (consumer checklist)

1. Check the category: Is it sold as a cosmetic, food, or supplement—and is that category permitted locally?
2. Verify third-party testing: Look for a COA with cannabinoids, contaminants (as applicable), and a matching batch number.
3. Scrutinize THC reporting: Ensure THC is clearly stated and appropriate for your country’s expectations.
4. Avoid medical claims: Be cautious of products claiming to “treat,” “cure,” or “prevent” conditions.
5. Know your destination rules: If traveling, check the destination country’s policy before packing CBD.

Internal resource: Expert Tips on CBD Selection

FAQs about CBD regulation in Europe

Is CBD legal in all European countries?

Not uniformly. Many countries allow some forms of CBD, but legality depends on product type (cosmetic vs. ingestible), THC compliance, and local enforcement.
Always check the rules in the specific country where you’re buying, selling, or traveling.

What does “novel food” mean for CBD products?

“Novel food” means the product (or ingredient) generally requires pre-market authorization in the EU because it wasn’t widely consumed before May 1997.
Many ingestible CBD extracts fall into this category, which can restrict sales until authorization is granted.

Can I travel with CBD within Europe?

It can be risky. A CBD product accepted in one country may be treated differently in another, especially if it contains detectable THC or is considered an unauthorized ingestible.
If you choose to travel with CBD, carry the original packaging and a COA, and confirm the destination’s rules in advance.

Does the EU have a single THC limit for CBD products?

There isn’t one universal THC limit that automatically applies to every CBD product category across all countries.
The EU sets a THC threshold for hemp cultivation, but finished-product rules and enforcement can still vary by country and by product type.

How can I tell if a CBD brand is taking compliance seriously?

Look for transparent labeling, batch-specific third-party testing (COAs), clear sourcing information, and conservative marketing that avoids medical claims.
Brands that publish compliance information and respond to customer questions with documentation are generally safer choices.